Cancer Prevention for Young Rural Adults
Launched by KLEIN BUENDEL, INC. · Nov 8, 2022
Trial Information
Current as of August 22, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Several risk factors are prevalent during early adulthood that can lead to cancer later in life. Emerging adults (EAs) aged 18-26 residing in rural areas of the United States engage in many cancer risk behaviors, especially sedentary lifestyles, poor eating patterns, nicotine product use, excess alcohol intake, infrequent sun protection, and inadequate uptake of the HPV vaccine. This application responds to RFA-CA-20-051, "Social and Behavioral Intervention Research to Address Modifiable Risk Factors for Cancer in Rural Populations." The goal is to improve cancer risk behavioral factors amo...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged 18-26 years old
- • Resides in a county coded as RUCC 4-9 in Arizona, Colorado, New Mexico, or Utah
- • Able to speak and read English
- • Has regular social media engagement
- • Accepts screening call from study staff
- • Consents to participate
- Exclusion Criteria:
- • Participated in community engagement activities
- • Cannot speak and read English
- • Has low or no social media engagement
- • Does not accept a screening call from study staff
- • Does not consent to participate
- • Does not give permission for engagement data to be extracted from Facebook private group
- • If biologically female, currently pregnant
About Klein Buendel, Inc.
Klein Buendel, Inc. is a specialized clinical trial sponsor dedicated to advancing health outcomes through innovative research and development. With a focus on behavioral interventions, the company leverages its expertise in health communication and technology to design and implement rigorous clinical studies. Klein Buendel collaborates with academic institutions and healthcare organizations to address critical health challenges, ensuring that their research is grounded in scientific excellence and real-world applicability. Committed to enhancing public health, the organization prioritizes the ethical conduct of research and the dissemination of findings to inform best practices in clinical care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Albuquerque, New Mexico, United States
Tucson, Arizona, United States
Aurora, Colorado, United States
Fort Collins, Colorado, United States
Salt Lake City, Utah, United States
Patients applied
Trial Officials
David Buller, PhD
Principal Investigator
Klein Buendel, Inc.
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials